L367-0465 Screening compound: 4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[2-(piperidin-1-yl)ethyl]benzamide

L367-0465 Screening compound: 4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[2-(piperidin-1-yl)ethyl]benzamide
L367-0465 Screening compound: 4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[2-(piperidin-1-yl)ethyl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L367-0465
4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[2-(piperidin-1-yl)ethyl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L367-0465

Molecular Formula

C24H33N5O (C24 H33 N5 O)

Compound Name

4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[2-(piperidin-1-yl)ethyl]benzamide

IUPAC name

4-[2-(cyclohexylamino)pyrimidin-5-yl]-N-[2-(piperidin-1-yl)ethyl]benzamide

SMILES

O=C(c(cc1)ccc1-c1cnc(NC2CCCCC2)nc1)NCCN1CCCCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.694

Distribution Coefficient, logD

2.694

Water Solubility, LogSw

-3.80

Polar Surface Area

58.913

Acid Dissociation Constant (pKa)

12.57

Base Dissociation Constant (pKb)

8.35

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

L367-0465 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

GPCR Targeted Library (31838 compounds)

Ion Channels Focused Library (26372 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L367-0465 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L367-0465?
Check Price and Availability of L367-0465, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L367-0465 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L367-0465
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L367-0465
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L367-0465 available by request